Heartflow (HTFL) Liabilities and Shareholders Equity (2024 - 2025)

Heartflow's (HTFL) quarterly Liabilities and Shareholders Equity came in at $359.5 million in Q4 2025, up 202.81% year-on-year from $118.7 million in Q4 2024, and down 1.36% quarter-over-quarter from $364.4 million in Q3 2025.

Heartflow (HTFL) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends

Heartflow's Liabilities and Shareholders Equity history runs 2 years deep, the most recent figure standing at $359.5 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 202.81% year-over-year to $359.5 million in Q4 2025; TTM through Dec 2025 was $1.0 billion, a 744.05% increase from a year earlier, with the FY2025 full-year figure at $359.5 million, up 202.81% from the prior year.
  • Liabilities and Shareholders Equity fell to $359.5 million in Q4 2025 per HTFL's latest filing, from $364.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $364.4 million in Q3 2025 and bottomed at $118.7 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Veeva Systems 31.99 Bn 24.68 Bn 662.02 Mn 9.13 Bn
2 BrightSpring Health Services 14.73 Bn 13.83 Bn 482.22 Mn 6.21 Bn
3 Healthequity 8.31 Bn 8.04 Bn 256.31 Mn 3.31 Bn
4 Hinge Health 5.99 Bn 5.67 Bn 154.23 Mn 728.77 Mn
5 10x Genomics 5.91 Bn 5.37 Bn 106.18 Mn 1.02 Bn
6 MiniMed 4.55 Bn 4.25 Bn 480.00 Mn 4.63 Bn
7 Waystar Holding 4.48 Bn 4.42 Bn 216.84 Mn 5.84 Bn
8 Doximity 3.96 Bn 3.21 Bn 125.97 Mn 1.12 Bn
9 Privia Health 3.15 Bn 2.73 Bn - 1.42 Bn
10 Heartflow 936.46 Mn 759.67 Mn 39.06 Mn 359.45 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 359.45 Mn
Sep 30, 2025 364.40 Mn
Jun 30, 2025 159.36 Mn
Dec 31, 2024 118.70 Mn